Appointment of Joint Broker

RNS Number : 6400S

Hutchison China Meditech Limited

15 September 2010

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Appointment of Joint Broker

London: Wednesday, 15 September 2010: Chi-Med today announces that it has appointed Piper Jaffray Ltd. as its joint broker.  Panmure Gordon (UK) Limited will continue to act as a broker of Chi-Med.

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone: [phone]  Mobile: [phone]  Mobile: [phone]
Lazard & Co., Limited Paul Gismondi Nick Fowler	Telephone: [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

APPFMGMLLDZGGZG